» Articles » PMID: 26223840

Substance P Enhances Microglial Density in the Substantia Nigra Through Neurokinin-1 Receptor/NADPH Oxidase-mediated Chemotaxis in Mice

Overview
Journal Clin Sci (Lond)
Date 2015 Jul 31
PMID 26223840
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The distribution of microglia varies greatly throughout the brain. The substantia nigra (SN) contains the highest density of microglia among different brain regions. However, the mechanism underlying this uneven distribution remains unclear. Substance P (SP) is a potent proinflammatory neuropeptide with high concentrations in the SN. We recently demonstrated that SP can regulate nigral microglial activity. In the present study, we further investigated the involvement of SP in modulating nigral microglial density in postnatal developing mice. Nigral microglial density was quantified in wild-type (WT) and SP-deficient mice from postnatal day 1 (P1) to P30. SP was detected at high levels in the SN as early as P1 and microglial density did not peak until around P30 in WT mice. SP-deficient mice (TAC1(-/-)) had a significant reduction in nigral microglial density. No differences in the ability of microglia to proliferate were observed between TAC1(-/-) and WT mice, suggesting that SP may alter microglial density through chemotaxic recruitment. SP was confirmed to dose-dependently attract microglia using a trans-well culture system. Mechanistic studies revealed that both the SP receptor neurokinin-1 receptor (NK1R) and the superoxide-producing enzyme NADPH oxidase (NOX2) were necessary for SP-mediated chemotaxis in microglia. Furthermore, genetic ablation and pharmacological inhibition of NK1R or NOX2 attenuated SP-induced microglial migration. Finally, protein kinase Cδ (PKCδ) was recognized to couple SP/NK1R-mediated NOX2 activation. Altogether, we found that SP partly accounts for the increased density of microglia in the SN through chemotaxic recruitment via a novel NK1R-NOX2 axis-mediated pathway.

Citing Articles

Peptide discovery across the spectrum of neuroinflammation; microglia and astrocyte phenotypical targeting, mediation, and mechanistic understanding.

Benita B, Koss K Front Mol Neurosci. 2024; 17:1443985.

PMID: 39634607 PMC: 11616451. DOI: 10.3389/fnmol.2024.1443985.


SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms.

Motyl J, Gromadzka G, Czapski G, Adamczyk A Int J Mol Sci. 2024; 25(22).

PMID: 39596147 PMC: 11593367. DOI: 10.3390/ijms252212079.


Focused ultrasound on the substantia nigra enables safe neurotensin-polyplex nanoparticle-mediated gene delivery to dopaminergic neurons intranasally and by blood circulation.

Mascotte-Cruz J, Vera A, Leija L, Lopez-Salas F, Gradzielski M, Koetz J Discov Nano. 2024; 19(1):60.

PMID: 38564106 PMC: 10987469. DOI: 10.1186/s11671-024-04005-9.


Microglial Activation in Metal Neurotoxicity: Impact in Neurodegenerative Diseases.

Martinez-Hernandez M, Acosta-Saavedra L, Hernandez-Kelly L, Loaeza-Loaeza J, Ortega A Biomed Res Int. 2023; 2023:7389508.

PMID: 36760476 PMC: 9904912. DOI: 10.1155/2023/7389508.


Neuroinflammation and Autophagy in Parkinson's Disease-Novel Perspectives.

Minchev D, Kazakova M, Sarafian V Int J Mol Sci. 2022; 23(23).

PMID: 36499325 PMC: 9735607. DOI: 10.3390/ijms232314997.


References
1.
Brownstein M, Mroz E, Kizer J, Palkovits M, Leeman S . Regional distribution of substance P in the brain of the rat. Brain Res. 1976; 116(2):299-305. DOI: 10.1016/0006-8993(76)90907-0. View

2.
Mittelbronn M, Dietz K, Schluesener H, Meyermann R . Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol. 2001; 101(3):249-55. DOI: 10.1007/s004010000284. View

3.
Yang T, Lin C, Hsu C, Wang T, Ke F, Kuo Y . Differential distribution and activation of microglia in the brain of male C57BL/6J mice. Brain Struct Funct. 2012; 218(4):1051-60. DOI: 10.1007/s00429-012-0446-x. View

4.
Metcalf D . The granulocyte-macrophage colony stimulating factors. Cell. 1985; 43(1):5-6. DOI: 10.1016/0092-8674(85)90004-2. View

5.
Graybiel A . Neuropeptides in the basal ganglia. Res Publ Assoc Res Nerv Ment Dis. 1986; 64:135-61. View